Riskpilot← Back to searchSign inGet full accessXercise Kristianstad AB
ABActiveOrg 5565730719Sävvägen 8Physiotherapy activities · NACE 8695Est. 19990 employees
Revenue 2024
SEK 1,1M
-7% vs 2023
EBITDA margin
24.0%
+96% vs 2023
Equity ratio
82.6%
Financial strength
Net profit 2024
SEK 188K
+24% vs 2023
| Revenue | SEK 1,1M | -7% |
| EBITDA | SEK 272K | +96% |
| Net profit | SEK 188K | +24% |
| Total assets | SEK 4M | +16% |
| Equity | SEK 3,3M | +6% |
| Employees | 0 | — |
Legal name
Xercise Kristianstad AB
Org number
5565730719
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
29 juli 1999
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastik, fysikträning, försäljning av tillbehör till denna verksamhet, caféservering samt därmed förenlig verksamhet.
Address
Sävvägen 8
Phone
+4644103520
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 872 | 1 226 | 1 096 | 1 213 | 1 132 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −257 | −269 | 277 | 139 | 272 |
| Depreciation & amort. | −74 | −137 | −137 | −0 | — |
| EBIT | −331 | −406 | 140 | 139 | 272 |
| Net financials | 14 | 245 | 118 | 12 | −2 |
| Profit before tax | −317 | −161 | 258 | 151 | 225 |
| Tax | −0 | −22 | −0 | −0 | −37 |
| Net profit | −317 | −183 | 258 | 151 | 188 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 696 | 3 402 | 3 683 | 3 419 | 3 952 |
| Equity | 3 040 | 2 667 | 2 925 | 3 076 | 3 263 |
| Long-term debt | 370 | 359 | 453 | 85 | 400 |
| Short-term debt | 287 | 376 | 306 | 259 | 244 |
| Total debt | 657 | 735 | 759 | 344 | 644 |
EBITDA margin
24.0%
This company
15.8%
Market median
+52% vs market
20202024
Equity ratio
82.6%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
5.8%
This company
18.4%
Market median
-68% vs market
20202024
Net profit margin
16.6%
This company
8.1%
Market median
+105% vs market
20202024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
LC Auditor Substitute | Auditor Substitute | 2022 – 2022 |
NM | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xercise Kristianstad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Charlotte Gustafsson | Auditor Substitute | 0 companies |
| Nils Martin Emil Sjörén | Audit | 0 companies |
| Petra Maria Therese Kempner | Deputy Board Member | 0 companies |
| Hans Robert Kempner | Board of Directors | 0 companies |